Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Breast-feeding, postpartum and prepregnancy disease activity in multiple sclerosis.
Episode 63 with Dr. Helen Tremlett on studying sun exposure in MS
Untangling TNF Trouble
Episode 50 with Dr. David Tabby on balance vests for MS
Immunomodulatory agents and risk of postpartum multiple sclerosis relapses.
ISN-APSN Biennial Meeting
Prevention and Mitigation of Experimental Autoimmune Encephalomyelitis by Murine β-Defensins via Induction of Regulatory T Cells.
Treatment of neuromyelitis optica with mycophenolate mofetil: retrospective analysis of 24 patients.
MS Research Roundup: January 17, 2014
Low testosterone is associated with disability in men with multiple sclerosis.
ECTRIMS 2013 Day 3
Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids.
Combination of IFN beta-1a (Avonex) and mycophenolate mofetil (Cellcept) in multiple sclerosis.
Promotion of central nervous system remyelination by induced differentiation of oligodendrocyte precursor cells.
ACTRIMS-ECTRIMS 2014 -- Day 3, morning
B-cell depletion with rituximab in relapsing-remitting multiple sclerosis.
Episode 40 with Dr. Raj Kapoor on a clinical trial of phenytoin
Mycophenolate mofetil improves neurological function and alters blood T-lymphocyte subsets in rats with experimental autoimmune encephalomyelitis.
USPTO list of patent term extensions
Nature Medicine Retracts MS Paper With Ghost Data by Former GSK Researcher
Epitope spreading as an early pathogenic event in pediatric multiple sclerosis.
Episode 47 with Dr. Hans Lassmann on oxidative stress in MS
High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation for Relapsing-Remitting Multiple Sclerosis (HALT-MS): A 3-Year Interim Report.
Episode 65 with Dr. Gisela Kobelt on the economics of long-term brain health in MS
TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group.

Pages